STAT News
- STAT+: Epic Systems defends competitive practices, promises to let AI access its recordsSTAT News ·
Executives from Epic, the largest electronics health records vendor, defended its competitive practices during a panel discussion at HLTH.
- STAT+: Influential preventive services panel to meet for first time in more than a yearSTAT News ·
A task force, meeting after a long delay, will discuss coverage of treatments for cervical cancer, perinatal depression, and alcohol use.
- STAT+: NIH to move last group of its research chimps to a sanctuarySTAT News ·
The last chimpanzees owned by the U.S. government and still living in a laboratory will be moved to a sanctuary next year.
- STAT+: 7 burning questions about the FDA’s post-Overton futureSTAT News ·
STAT tackles the most important questions about the FDA's uncertain future.
- STAT+: The emerging winners and losers in the AI scribe marketSTAT News ·
In this edition of AI Prognosis: A closer look at how the AI scribe market is shaking out, news from the HLTH conference, and more
- STAT+: Cassidy rejects Trump’s pick to lead NSF, saying he failed to ‘stand up for science’STAT News ·
Bill Cassidy's rejection of Jim O'Neill comes shortly after the White House pulled FDA commissioner nominee Heidi Overton.
- STAT+: FDA discloses reasons for rejecting Summit drugSTAT News ·
The FDA published its complete response letter to Summit Therapeutics explaining why it rejected the biotech's closely watched lung cancer drug:
- STAT+: Pharmalittle: We’re reading about Overton FDA nomination being yanked, a Merck setback, and moreSTAT News ·
The Trump administration is pulling the nomination of Heidi Overton to lead the FDA over concerns she lacked support to get confirmed by the Senate
- What redesigning medical school might look likeSTAT News ·
"I am asking whether every part of [the medical school] infrastructure needs to be bundled into the same four-year institution,” writes M.D./Ph.D. student Alex Serafini.
- Opinion: Maybe in-person four-year institutions aren’t the right approach to medical educationSTAT News ·
“Why do we have hundreds of institutions independently building parallel versions of the same pre-clerkship curriculum?”
- STAT+: Scientists heralded a blue wave. But will they miss Susan Collins?STAT News ·
Some science advocates worry that Maine GOP Sen. Susan Collins’ defeat could hamper their ability to push back on Trump administration research policies.
- Opinion: STAT+: RFK Jr. has got to goSTAT News ·
With Democrats riding a blue wave after the midterms, it’s time to impeach health secretary Robert F. Kennedy Jr., writes Paul Knoepfler.
- STAT+: White House pulls nomination of Heidi Overton to lead FDASTAT News ·
BREAKING: The White House is pulling its nominee to be commissioner of the FDA, Heidi Overton.
- STAT+: Updated health data privacy rule sets standards for sharing records with appsSTAT News ·
Federal health department has updated the HIPAA privacy rule with a focus on supporting patients’ access to their own medical records.
- STAT+: GOP, MAHA leaders clash over FDA nominee’s record on vapesSTAT News ·
Heidi Overton is facing an uphill climb to become the next FDA commissioner. The latest challenge is her work on vaping.
- STAT+: What to know about the new AI roadmap from CMS, and news from HLTHSTAT News ·
In this edition of STAT Health Tech: What you need to know about CMS' recently released AI roadmap, and highlights from HLTH.
- STAT+: Flagship opens biotech-creation outpost in the U.K.STAT News ·
Flagship is putting up 100 million pounds to start “AI-native platform companies" focused on human and planetary health in the U.K.:
- U.S. loses measles elimination status, marking embarrassing stain on its public health recordSTAT News ·
Measles is no longer considered eliminated in the U.S., a finding that was expected but that marks an embarrassing backslide in the country’s basic public health standing.
- STAT+: ‘Medicare for More’ gains tractionSTAT News ·
Democrats coalesce around a new health care policy, and Trump's new chief of staff embraces MAHA.
- STAT+: Pharmalittle: We’re reading about a Roche breast cancer pill, obesity drugs in children, and moreSTAT News ·
The FDA approved a breast cancer drug from Roche, teeing up the launch of what the company has said could become its top-selling product
- NIH’s infectious disease unit has a new head at lastSTAT News ·
The NIH has been without a permanent director since 2025. Now officials announce that acting director John Powers III will take the helm.
- STAT+: Sellas’ experimental blood cancer immunotherapy reduced risk of death in clinical trialSTAT News ·
Sellas' experimental blood cancer immunotherapy reduced the risk of death in clinical trial.
- STAT+: With $173 million, new startup takes aim at sickle cellSTAT News ·
Researchers are seeking a sickle cell treatment as effective as gene therapy, without the drawbacks. This entrepreneur thinks he might have one.
- Faith-based addiction recovery groups don’t often get federal funding. RFK Jr. wants to change thatSTAT News ·
As RFK Jr. pushes federal support for faith-based recovery groups, medical experts express concern over access to addiction medications.
- STAT+: After death in gene therapy trial for a brain disease, progress is reportedSTAT News ·
An unexpected patient death rattled researchers who sought to pierce the blood-brain barrier. Now some think they have a better way of mitigating risks.
- Flavored nicotine tablets, the tobacco industry’s latest product, worry public health advocatesSTAT News ·
The latest product from the tobacco industry is a flavorful nicotine tablet that melts in your mouth, allowing users to get a buzz as discreetly as popping a mint
- Opinion: The problem with ‘zero tolerance for bad behavior’ signs at hospitalsSTAT News ·
“Hospitals do not have to choose between protecting hospital staff and preserving patient/family trust in the institution.”
- STAT+: New Trump regulation promises to crush ‘fraudsters.’ All the savings come from Medicare AdvantageSTAT News ·
New Trump regulation promises to crush ‘fraudsters.’ All the savings come from Medicare Advantage.
- STAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for RocheSTAT News ·
The FDA approved a new breast cancer drug from Roche, teeing up the launch of a medicine the company has said could become its top-selling product ever.
- STAT+: Federal judge issues final ruling blocking U.S. plan to limit visa length for grad students, postdocsSTAT News ·
A proposal by the Trump administration to cap the amount of time foreign students and scholars can spend in the country has been struck down in court.
- STAT+: In a win for MAHA, FDA creates new regulatory category for the supplement NACSTAT News ·
The supplement NAC has been widely available for years, but exists in a legal gray area.
- STAT+: Newer GLP-1 drugs to combat obesity may be the next global battleground over access to medicines, expert warnsSTAT News ·
How obesity medications may become the next big battleground over access to medicines in lower-income countries.
- STAT+: NIAID acting head John Powers III appointed as the permanent directorSTAT News ·
The acting director of NIAID, John Powers III, will become the permanent director, the agency announced Monday.
- STAT+: Biotech’s rebound isn’t lifting all boats equallySTAT News ·
Biotech is having a good year, though you wouldn't necessarily know it from how investors are treating positive clinical data.
- STAT+: Suing Joe the Plumber and Microsoft, and diminishing raisesSTAT News ·
Health care providers turn to the courts to get paid, and how insurance costs are eating your paycheck.
- STAT+: Pharmalittle: We’re reading about GLP-1 use, Covid-19 vaccine investment returns, and moreSTAT News ·
During July and August 2025, approximately 1 in 10 U.S. adults reported taking a GLP-1 medication during the previous year
- Democrats settle on a message: ‘Medicare for More’STAT News ·
It doesn’t have quite the same ring to it as “Medicare for All.” But House Dems have coalesced around a policy priority to expand health care access:
- STAT+: Helus’ psychedelic drug improved depression in study but faces safety questionsSTAT News ·
A psychedelic drug from Helus Pharma improved depression in a study, but is facing safety questions with a number of serious adverse events reported.
- STAT+: Bladder cancer immunotherapy from CG Oncology reduced risk of tumor recurrenceSTAT News ·
CG Oncology's bladder cancer immunotherapy reduced risk of tumor recurrence by 68% — results that may change how physicians treat certain patients.
- STAT+: Venture capitalist John Doerr says AI company, named for his late brother, could help fix primary careSTAT News ·
Venture capitalist John Doerr on Tom Health, a new AI tool for primary care: "I think this is one of the best possible uses of AI."
- STAT+: Versant, Lilly put $100 million behind new startup aimed at solving one of gene therapy’s thorniest issuesSTAT News ·
Versant Ventures, Eli Lilly, and a handful of other investors will pour $100 million into a new startup devoted to solving a thorny gene therapy challenge.
- After difficult two years, medical school group’s leadership isn’t letting its guard down post midtermsSTAT News ·
After a tumultuous two years entangled in many consequential health and science policy debates, AAMCs isn’t ready to let its guard down.
- BeOne, Hengrui top list of China’s most powerful drugmakersSTAT News ·
A new STAT-WireScreen index ranks China's most valuable publicly traded biotech companies. See which one topped the list.
- Opinion: Medical school should start after students take the Step 1 examSTAT News ·
“It’s time for a radical reimagining of medical education,” write Rachel Fabi and Amy Caruso Brown.
- Opinion: STAT+: Candles and long baths can’t fix burned-out physiciansSTAT News ·
The language around self-care for doctors puts the onus on them to fix themselves. But the system is to blame, writes Frances Mei Hardin.
- STAT+: With Stephen Miller as chief of staff, Kennedy’s MAHA agenda is reinvigoratedSTAT News ·
The appointment of Stephen Miller as White House chief of staff has health secretary RFK Jr. invigorated. A top deputy is telling people it's go time for MAHA.
- STAT+: Apple and OpenEvidence launch experimental health chat appSTAT News ·
Apple and OpenEvidence are launching a study based around an experimental AI-powered health chat app, hinting at possible new directions for both companies.
- STAT+: FDA rejects lung cancer treatment ivonescimab from Summit TherapeuticsSTAT News ·
The FDA has rejected ivonescimab, a treatment for a type of lung cancer developed by U.S. biotech Summit Therapeutics and the Chinese drugmaker Akeso.
- STAT+: Enforcement of stringent Medicaid work requirements delayed for six monthsSTAT News ·
Enforcement of the Trump administration's stringent new Medicaid work requirements have been delayed for six months, until July 1, 2027.
- STAT+: Democrats coalesce around ‘Medicare for More,’ ‘Medikids’ proposalsSTAT News ·
Democrats are coalescing around a plan to offer Medicare to more Americans, if not all of them.